KO | ||
---|---|---|
OUTLOOK RATING 1..100 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 15 | |
SMR RATING 1..100 | 21 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 72 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GINX | KO | |
---|---|---|
RSI ODDS (%) | 1 day ago40% | N/A |
Stochastic ODDS (%) | 1 day ago60% | 1 day ago45% |
Momentum ODDS (%) | 1 day ago73% | 1 day ago37% |
MACD ODDS (%) | 1 day ago63% | 1 day ago31% |
TrendWeek ODDS (%) | 1 day ago87% | 1 day ago35% |
TrendMonth ODDS (%) | 1 day ago83% | 1 day ago33% |
Advances ODDS (%) | 1 day ago88% | 4 days ago41% |
Declines ODDS (%) | 3 days ago59% | 1 day ago32% |
BollingerBands ODDS (%) | 1 day ago58% | 1 day ago45% |
Aroon ODDS (%) | 1 day ago87% | 1 day ago38% |
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
---|---|---|---|---|
GINX | 100% | +0.15% | ||
GSK - GINX | 24% Poorly correlated | +2.25% | ||
RELX - GINX | 21% Poorly correlated | +0.53% | ||
KMB - GINX | 21% Poorly correlated | +1.55% | ||
NVS - GINX | 20% Poorly correlated | +1.02% | ||
KO - GINX | 20% Poorly correlated | -0.42% | ||
More |